ID   ACSM3_HUMAN             Reviewed;         586 AA.
AC   Q53FZ2; O60363; Q13732; Q15425; Q7KYM6; Q9BUA2;
DT   02-OCT-2007, integrated into UniProtKB/Swiss-Prot.
DT   02-OCT-2007, sequence version 2.
DT   10-MAY-2017, entry version 107.
DE   RecName: Full=Acyl-coenzyme A synthetase ACSM3, mitochondrial;
DE            EC=6.2.1.2;
DE   AltName: Full=Acyl-CoA synthetase medium-chain family member 3;
DE   AltName: Full=Butyrate--CoA ligase 3;
DE   AltName: Full=Butyryl-coenzyme A synthetase 3;
DE   AltName: Full=Middle-chain acyl-CoA synthetase 3;
DE   AltName: Full=Protein SA homolog;
DE   Flags: Precursor;
GN   Name=ACSM3; Synonyms=SAH;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Liver;
RX   PubMed=7907320; DOI=10.1161/01.HYP.23.3.375;
RA   Iwai N., Ohmichi N., Hanai K., Nakamura Y., Kinoshita M.;
RT   "Human SA gene locus as a candidate locus for essential
RT   hypertension.";
RL   Hypertension 23:375-380(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND LACK OF INVOLVEMENT IN
RP   HEREDITARY HYPERTENSION.
RX   PubMed=7843754; DOI=10.1161/01.HYP.25.1.6;
RA   Nabika T., Bonnardeaux A., James M., Julier C., Jeunemaitre X.,
RA   Corvol P., Lathrop M., Soubrier F.;
RT   "Evaluation of the SA locus in human hypertension.";
RL   Hypertension 25:6-13(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=10493829; DOI=10.1006/geno.1999.5927;
RA   Loftus B.J., Kim U.-J., Sneddon V.P., Kalush F., Brandon R.,
RA   Fuhrmann J., Mason T., Crosby M.L., Barnstead M., Cronin L.,
RA   Mays A.D., Cao Y., Xu R.X., Kang H.-L., Mitchell S., Eichler E.E.,
RA   Harris P.C., Venter J.C., Adams M.D.;
RT   "Genome duplications and other features in 12 Mb of DNA sequence from
RT   human chromosome 16p and 16q.";
RL   Genomics 60:295-308(1999).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   ASN-367.
RC   TISSUE=Kidney;
RA   Suzuki Y., Sugano S., Totoki Y., Toyoda A., Takeda T., Sakaki Y.,
RA   Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [8]
RP   VARIANT ASN-367.
RX   PubMed=17278971; DOI=10.1097/HJH.0b013e3280144779;
RA   Telgmann R., Brand E., Nicaud V., Hagedorn C., Beining K.,
RA   Schoenfelder J., Brink-Spalink V., Schmidt-Petersen K., Matanis T.,
RA   Vischer P., Nofer J.-R., Hasenkamp S., Plouin P.-F., Drouet L.,
RA   Cambien F., Paul M., Tiret L., Brand-Herrmann S.-M.;
RT   "SAH gene variants are associated with obesity-related hypertension in
RT   Caucasians: the PEGASE Study.";
RL   J. Hypertens. 25:557-564(2007).
CC   -!- FUNCTION: Has medium-chain fatty acid:CoA ligase activity with
CC       broad substrate specificity (in vitro). Acts on acids from C(4) to
CC       C(11) and on the corresponding 3-hydroxy- and 2,3- or 3,4-
CC       unsaturated acids (in vitro) (By similarity). {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY: ATP + a carboxylate + CoA = AMP + diphosphate
CC       + an acyl-CoA.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000250};
CC   -!- SUBCELLULAR LOCATION: Mitochondrion matrix {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q53FZ2-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q53FZ2-2; Sequence=VSP_028395, VSP_028396;
CC   -!- SIMILARITY: Belongs to the ATP-dependent AMP-binding enzyme
CC       family. {ECO:0000305}.
CC   -!- CAUTION: It is uncertain whether Met-1 or Met-9 is the initiator.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC31667.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=BAA03853.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=CAA56369.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D16350; BAA03853.1; ALT_INIT; mRNA.
DR   EMBL; X80062; CAA56369.1; ALT_INIT; mRNA.
DR   EMBL; AC004381; AAC31667.1; ALT_INIT; Genomic_DNA.
DR   EMBL; AK223139; BAD96859.1; -; mRNA.
DR   EMBL; BC002790; AAH02790.3; -; mRNA.
DR   CCDS; CCDS10589.1; -. [Q53FZ2-1]
DR   CCDS; CCDS45435.1; -. [Q53FZ2-2]
DR   PIR; I54401; I54401.
DR   PIR; S69913; S69913.
DR   RefSeq; NP_005613.2; NM_005622.3. [Q53FZ2-1]
DR   RefSeq; NP_973729.1; NM_202000.2. [Q53FZ2-2]
DR   UniGene; Hs.706754; -.
DR   ProteinModelPortal; Q53FZ2; -.
DR   SMR; Q53FZ2; -.
DR   BioGrid; 112203; 1.
DR   IntAct; Q53FZ2; 1.
DR   STRING; 9606.ENSP00000289416; -.
DR   SwissLipids; SLP:000001189; -.
DR   iPTMnet; Q53FZ2; -.
DR   PhosphoSitePlus; Q53FZ2; -.
DR   BioMuta; ACSM3; -.
DR   DMDM; 158706483; -.
DR   MaxQB; Q53FZ2; -.
DR   PaxDb; Q53FZ2; -.
DR   PeptideAtlas; Q53FZ2; -.
DR   PRIDE; Q53FZ2; -.
DR   DNASU; 6296; -.
DR   Ensembl; ENST00000289416; ENSP00000289416; ENSG00000005187. [Q53FZ2-1]
DR   Ensembl; ENST00000440284; ENSP00000394565; ENSG00000005187. [Q53FZ2-2]
DR   GeneID; 6296; -.
DR   KEGG; hsa:6296; -.
DR   UCSC; uc002dhq.4; human. [Q53FZ2-1]
DR   CTD; 6296; -.
DR   DisGeNET; 6296; -.
DR   GeneCards; ACSM3; -.
DR   H-InvDB; HIX0079728; -.
DR   H-InvDB; HIX0079834; -.
DR   HGNC; HGNC:10522; ACSM3.
DR   HPA; HPA041013; -.
DR   MalaCards; ACSM3; -.
DR   MIM; 145505; gene.
DR   neXtProt; NX_Q53FZ2; -.
DR   OpenTargets; ENSG00000005187; -.
DR   PharmGKB; PA34930; -.
DR   eggNOG; KOG1175; Eukaryota.
DR   eggNOG; COG0365; LUCA.
DR   GeneTree; ENSGT00760000119178; -.
DR   HOGENOM; HOG000229982; -.
DR   HOVERGEN; HBG053031; -.
DR   InParanoid; Q53FZ2; -.
DR   KO; K01896; -.
DR   OMA; AIPKAYV; -.
DR   OrthoDB; EOG091G03NW; -.
DR   PhylomeDB; Q53FZ2; -.
DR   TreeFam; TF354287; -.
DR   Reactome; R-HSA-77352; Beta oxidation of butanoyl-CoA to acetyl-CoA.
DR   ChiTaRS; ACSM3; human.
DR   GeneWiki; ACSM3; -.
DR   GenomeRNAi; 6296; -.
DR   PRO; PR:Q53FZ2; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   Bgee; ENSG00000005187; -.
DR   CleanEx; HS_ACSM3; -.
DR   ExpressionAtlas; Q53FZ2; baseline and differential.
DR   Genevisible; Q53FZ2; HS.
DR   GO; GO:0005759; C:mitochondrial matrix; IBA:GO_Central.
DR   GO; GO:0003996; F:acyl-CoA ligase activity; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0047760; F:butyrate-CoA ligase activity; TAS:Reactome.
DR   GO; GO:0015645; F:fatty acid ligase activity; IBA:GO_Central.
DR   GO; GO:0004321; F:fatty-acyl-CoA synthase activity; IBA:GO_Central.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0006637; P:acyl-CoA metabolic process; IBA:GO_Central.
DR   GO; GO:0042632; P:cholesterol homeostasis; NAS:BHF-UCL.
DR   GO; GO:0006635; P:fatty acid beta-oxidation; TAS:Reactome.
DR   GO; GO:0006633; P:fatty acid biosynthetic process; IBA:GO_Central.
DR   GO; GO:0008217; P:regulation of blood pressure; TAS:ProtInc.
DR   InterPro; IPR025110; AMP-bd_C.
DR   InterPro; IPR020845; AMP-binding_CS.
DR   InterPro; IPR000873; AMP-dep_Synth/Lig.
DR   Pfam; PF00501; AMP-binding; 1.
DR   Pfam; PF13193; AMP-binding_C; 1.
DR   PROSITE; PS00455; AMP_BINDING; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; ATP-binding; Complete proteome;
KW   Fatty acid metabolism; Ligase; Lipid metabolism; Magnesium;
KW   Metal-binding; Mitochondrion; Nucleotide-binding; Polymorphism;
KW   Reference proteome; Transit peptide.
FT   TRANSIT       1     27       Mitochondrion. {ECO:0000255}.
FT   CHAIN        28    586       Acyl-coenzyme A synthetase ACSM3,
FT                                mitochondrial.
FT                                /FTId=PRO_0000306097.
FT   NP_BIND     235    243       ATP. {ECO:0000250}.
FT   NP_BIND     374    379       ATP. {ECO:0000250}.
FT   BINDING     461    461       ATP. {ECO:0000250}.
FT   BINDING     476    476       ATP. {ECO:0000250}.
FT   BINDING     572    572       ATP. {ECO:0000250}.
FT   MOD_RES      73     73       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q3UNX5}.
FT   MOD_RES     106    106       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q3UNX5}.
FT   MOD_RES     157    157       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q3UNX5}.
FT   VAR_SEQ     409    438       IVDVNGNVLPPGQEGDIGIQVLPNRPFGLF -> VCTSPSR
FT                                RMFNNPICTLPTYRLPPYKLSLL (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:7843754}.
FT                                /FTId=VSP_028395.
FT   VAR_SEQ     439    586       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:7843754}.
FT                                /FTId=VSP_028396.
FT   VARIANT     100    100       L -> P (in dbSNP:rs5713).
FT                                /FTId=VAR_035249.
FT   VARIANT     270    270       D -> H (in dbSNP:rs13306603).
FT                                /FTId=VAR_048239.
FT   VARIANT     308    308       P -> T (in dbSNP:rs7196188).
FT                                /FTId=VAR_035250.
FT   VARIANT     367    367       K -> N (in dbSNP:rs5716).
FT                                {ECO:0000269|PubMed:17278971,
FT                                ECO:0000269|Ref.4}.
FT                                /FTId=VAR_035251.
FT   CONFLICT    132    132       E -> R (in Ref. 1; BAA03853).
FT                                {ECO:0000305}.
FT   CONFLICT    237    237       G -> A (in Ref. 1; BAA03853).
FT                                {ECO:0000305}.
FT   CONFLICT    245    245       T -> S (in Ref. 1; BAA03853).
FT                                {ECO:0000305}.
FT   CONFLICT    407    407       V -> D (in Ref. 4; BAD96859).
FT                                {ECO:0000305}.
FT   CONFLICT    463    463       G -> A (in Ref. 1; BAA03853).
FT                                {ECO:0000305}.
FT   CONFLICT    569    569       I -> V (in Ref. 1; BAA03853).
FT                                {ECO:0000305}.
SQ   SEQUENCE   586 AA;  66153 MW;  329967C751F11F1D CRC64;
     MLARVTRKML RHAKCFQRLA IFGSVRALHK DNRTATPQNF SNYESMKQDF KLGIPEYFNF
     AKDVLDQWTD KEKAGKKPSN PAFWWINRNG EEMRWSFEEL GSLSRKFANI LSEACSLQRG
     DRVILILPRV PEWWLANVAC LRTGTVLIPG TTQLTQKDIL YRLQSSKANC IITNDVLAPA
     VDAVASKCEN LHSKLIVSEN SREGWGNLKE LMKHASDSHT CVKTKHNEIM AIFFTSGTSG
     YPKMTAHTHS SFGLGLSVNG RFWLDLTPSD VMWNTSDTGW AKSAWSSVFS PWIQGACVFT
     HHLPRFEPTS ILQTLSKYPI TVFCSAPTVY RMLVQNDITS YKFKSLKHCV SAGEPITPDV
     TEKWRNKTGL DIYEGYGQTE TVLICGNFKG MKIKPGSMGK PSPAFDVKIV DVNGNVLPPG
     QEGDIGIQVL PNRPFGLFTH YVDNPSKTAS TLRGNFYITG DRGYMDKDGY FWFVARADDV
     ILSSGYRIGP FEVENALNEH PSVAESAVVS SPDPIRGEVV KAFVVLNPDY KSHDQEQLIK
     EIQEHVKKTT APYKYPRKVE FIQELPKTIS GKTKRNELRK KEWKTI
//
